Start­up that mines ‘junk DNA’ se­cures R&D deal with Mer­ck

Epi­to­pea has inked a li­cense and re­search col­lab­o­ra­tion with Mer­ck to dis­cov­er new tu­mor-spe­cif­ic anti­gens from so-called “dark mat­ter” DNA, which are parts of the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER